Showing posts with label Sydney. Show all posts
Showing posts with label Sydney. Show all posts

Monday, May 7, 2012

[VIDEO] McGowan and Pickett Talk the Rectal Microbicide Walk at Microbicides 2012

Rectal microbicides were ALL OVER the Microbicides 2012 conference...


Chatting up rectal microbicide research and advocacy activities and issues at the recent Microbicides 2012 conference (held in Sydney this past April) were Dr. Ian McGowan, co-principal investigator of the Microbicide Trials Network (and IRMA Scientific Co-Chair) and IRMA Chair Jim Pickett.

Have a look/listen to their discussion with reporters.



 

*Check out pics from the Microbicides 2012 conference on IRMA's Facebook page.

-------------------


*Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

-------------------

 


Monday, March 19, 2012

Join IRMA and Partners for Dynamic Microbicides 2012 Advocates’ Pre-conference!

Please join us for this dynamic pre-conference….


Advocacy in a New Prevention Landscape:

BUILDING OUR KNOWLEDGE AND CAPACITY FOR EFFECTIVE ADVOCACY
AROUND HIV PREVENTION RESEARCH AND IMPLEMENTATION


Timing: Sunday 15 April 2012, 0830 to 1600
Venue: Sydney Convention & Exhibition Centre, Darling Harbour, Sydney

 
M2012 offers new opportunities and challenges to advocates across the world involved and/or interested in advocacy around microbicides and other HIV prevention research and rollout. We have new tools to consider in HIV prevention with the exciting results from PrEP and treatment as prevention trials - and yet confusing results from the early termination of the FEM-PrEP trial and the microbicide gel and tenofovir tablet arms of the VOICE study. What does this mean for communities and how does it affect the work we do as advocates?


The African Microbicides Advocacy Group, AVAC, the Global Campaign for Microbicides, IRMA (International Rectal Microbicides Advocates), the New HIV Vaccine & Microbicide Advocacy Society and local Australian partners ACON and AFAO will hold a day-long pre-conference workshop on Sunday, April 15. The M2012 Advocates' Pre-Conference Workshop will begin at 08:30 and conclude by 16:00, ensuring participants have ample time to get to the M2012 opening ceremony. The workshop will be held at the Sydney Convention & Exhibition Centre, and lunch will be provided.


The goal of the workshop is to equip new and experienced advocates, community representatives, trial staff and others with the tools needed to fully participate in the M2012 Conference by:

• Providing an overview of the field to contextualize the themes and issues presented at M2012;

• Connecting research and advocacy priorities and exploring common goals;

• Building capacity of advocates and trial staff to better engage with emerging issues in the field.


The pre-conference workshop will feature seasoned advocates and researchers from the HIV prevention research field who will provide participants with updates and previews to topics to be presented at the conference. An array of thematic discussion and skills-building sessions will be conducted including an update on key issues in the field, influencing relevant country policies and processes, prevention research literacy and ethics, and training on advocacy and campaign building.


Registration for this workshop is free for all interested participants but has limited space so registration will be offered on first-come first-served basis.


Registrations will be accepted through 23 March 2012 or until we have reached capacity.


To register – please fill this registration form at https://www.surveymonkey.com/s/39SPS5P. If you have any questions or having problems with the registration form, please write to M2012AdvocatesPrecon@gmail.com.


Organizers: AMAG, AVAC, GCM, IRMA and NHVMAS with Australian Partners ACON and AFAO


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Friday, November 11, 2011

Microbicides 2012 - Abstract and Scholarships Deadline EXTENDED TO FRIDAY 25 NOVEMBER 2011

IMPORTANT UPDATE:

Due to popular demand the deadline for the 2012 International Microbicides Conference abstract submissions and scholarship applications has been extended until Friday 25 November 2011!

Keep in mind that the date is actually November 24 for much of the world.



[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Wednesday, November 9, 2011

Microbicides 2012 Abstract and Scholarship Deadlines - November 17 (Aussie time)


Heads up IRMA, you have little more than a week to submit abstracts and apply for scholarships for the Microbicides 2012 conference scheduled for April 15 - 18, 2012 in Sydney, Australia.

Please take special note of the time - as Nov 17 in Australia could very well be Nov 16 where you are.

Here is the website: http://microbicides2012.org/

Here are key dates:

Abstract Submission

Thursday 17 November 2011 (Authors should submit abstracts no later than 5pm AEST time on Thursday 17 November 2011. TAKE NOTE OF THIS TIME and figure out what it means in your time zone - it will likely be much earlier, or even the day before.)

Scholarship Application

Thursday 17 November 2011 (Scholarship applications must be submitted online no later than 5:00 p.m Australian Eastern Standard Time - again, TAKE NOTE OF THIS TIME and figure out what that means in your time zone).
Successful applicants will be informed by e-mail after 16 January 2012.

Early Bird Registration
Tuesday 31 January 2012

Late Breaker Abstracts
Sunday 13 February 2012

Accommodation Booking
Friday 9 March 2012

Standard Registration
Thursday 15 March 2012

Conference Registration
Friday 30 March 2012

Conference
15 - 18 April 2012



[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Friday, July 22, 2011

SAVE THE DATE: M2012 is coming to Sydney, April 2012

The M2012 International Microbicides Conference is fast approaching. The conference will be held at Sydney Convention and Exhibition Centre, Sydney, Australia from Sunday 15 April to Wednesday 18 April 2012. It's time to make sure you mark these dates in your diary. 

Click here to learn more, including deadlines for early bird registration, abstract submissions and scholarship 

For more information or to register your interest please visit the website www.microbicides2012.org.

Also, please be aware that IRMA is working with other partners on a pre-conference - to be held Sunday April 15 before the full conference opening - and an Advocacy Corner. If you are interested, let us know.


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Wednesday, October 27, 2010

Cheeky! IRMA Chair Chats Up Microbicides, Lube Safety, and No Promo Homo

Rapid HIV testing: Australia's 'big embarrassment'
via SX and CityVoice (Sydney), by Brendan Bolger
...Anal sex could be playing an important role in (heterosexual) HIV transmission. Vulnerable women have unprotected anal sex. Anal sex is used as contraception...
Read the rest.

Monday, October 12, 2009

Factors associated with unprotected anal intercourse between HIV-positive men and regular male partners in a Sydney cohort

Int J STD AIDS. 2009 Oct;20(10):704-7.


Begley K, Chan DJ, Jeganathan S, Batterham M, Smith DE.
Albion Street Centre, Prince of Wales Hospital, Sydney.

Blood plasma HIV-RNA load (BPVL) is the strongest predictor of HIV-1 transmission during sex. Unprotected anal intercourse (UAI) is the highest risk activity for transmission among men who have sex with men (MSM). Awareness of BPVL may influence rates of UAI. We assessed whether optimism towards antiretroviral therapy (ART) and/or biomedical factors influenced sexual activities with regular partners. Questionnaires were administered to 109 HIV-positive MSM participating in a cross-sectional study of BPVL and seminal viral load. The survey assessed HIV transmission beliefs and sexual practices with regular male partners in the past three months. Sixty-nine of 109 (63.3%) had been in a regular relationship and 42 reported having had anal sex. Unprotected receptive anal intercourse without ejaculation (URAI - e) was associated with awareness that their most recent BPVL was detectable (>50 RNA copies/mL) and not taking ART. Receptive UAI with ejaculation (URAI + e) was associated with not taking ART, having a sexually transmissible infection and having an HIV-positive partner; the latter was also associated with insertive UAI with ejaculation (UIAI + e). Treatment optimism was not associated with UAI.In this cohort, sexual practices were based more upon knowledge of biomedical factors rather than attitudes regarding transmission risks.

PMID: 19815916 [PubMed - in process]

Friday, January 16, 2009

Risk reduction strategies are safer for Sydney gay men than other unprotected sex practices - but less safe than consistent condom use

via Aidsmap.

Gay men in Sydney who only have unprotected anal intercourse as part of a risk reduction strategy such as serosorting or negotiated safety have a considerably lower risk of acquiring HIV than men who have unprotected sex in other ways, report Australian researchers in the January 14th issue of AIDS.

Men who have unprotected anal intercourse only as the insertive partner, and those who ensure that their partner withdraws before ejaculation, also had a lower risk of acquiring HIV than men who don't employ any form of risk reduction strategy when they have unprotected anal intercourse.

Taken together, men using any of these practices were three times more likely to acquire HIV than men who had no unprotected anal intercourse (UAI). However men who practiced UAI without any of these safeguards were almost eleven times more likely than men having no UAI to acquire HIV.

Moreover, withdrawal before ejaculation was the riskiest practice studied. It was associated with a five fold increase in the risk of infection (compared to no UAI).

These strategies have been used by gay men for many years and some scientists consider them to be biologically plausible, but until now there has been limited evidence on their effectiveness in the real world. One important study came in 2007 when Fengyi Jin reported that a third of Australian gay seroconverters had tried to employ a risk reduction strategy.

Read the rest.

Editorial

In an editorial accompanying the Australian report, Frits van Griensven of the Thailand Ministry of Public Health and U.S. Centers for Disease Control asked if non-condom risk-reduction behaviors can help contain the spread of HIV infection among MSM.

"In a world where condom use during anal intercourse has been the cornerstone of HIV prevention among MSM, it is remarkable that all these risk-reduction behaviors include anal intercourse without condom use, he wrote. "This inevitably raises the question why the sexual behavior identified as the primary driver of the HIV epidemic in MSM has become the central component of HIV risk-reduction behaviors employed by MSM."

"The answer lies in how institutional and individual HIV-prevention strategies have evolved over the past 25 years," he continued. In the early years of the epidemic, HIV prevention for MSM was based on the principle of "risk-elimination," such as avoidance of any unprotected anal intercourse. "Because anal intercourse appeared to be too difficult to change," he wrote, condom use soon became the norm in HIV prevention among MSM, and widespread changes in sexual behavior led to a dramatic decrease in HIV transmission among gay/bisexual men in the Western world.

HIV prevention based on risk elimination "probably worked well until the mid-1990s," van Griensven continued, at which point men started to develop "safe-sex fatigue" and began looking for alternative prevention strategies. Around the same time, younger generations of gay/bisexual men came of age who "had not personally experienced the devastating effects of AIDS in the MSM community," and the advent of HAART led many men "to no longer view HIV infection as a death sentence but as a manageable chronic disease."

With these developments, "Risk for HIV infection was no longer seen as constant across partners, but varied according to certain conditions, such as partner characteristics (e.g. serostatus) or sexual position in anal sex (e.g. insertive versus receptive intercourse)," he wrote. But, he noted, until now there have been no solid data on such risk-reduction strategies from prospective studies.

In summary, he wrote, based on the Australian data, "we can say that with the exception of withdrawal and possibly serosorting, risk-reduction behaviors in this population of MSM were equally to somewhat less effective in preventing HIV infection than was no unprotected anal intercourse."

"Serosorting and negotiated safety require honest communication between partners who are accurately informed about their HIV status, whereas the effect of strategic positioning is supported by epidemiologic data indicating the decreased risk of insertive anal intercourse compared to receptive anal intercourse," he continued. "The risk of withdrawal during unprotected receptive anal intercourse has not been well documented, but this practice seems unreliable because of possible exposure to body fluids and cells, including those from untimely withdrawal and pre-ejaculate."

Looking at the conditions under which non-condom risk-reduction behaviors can be effective, van Griensven wrote, "First of all it is crucial that MSM have updated and accurate information about their HIV serostatus…Second, HIV seropositive MSM need to be willing to disclose their HIV serostatus…Third, strategic positioning needs to be common, with HIV seronegative men taking the insertive and HIV seropositive men taking the receptive role in anal and oral sex."

He suggested that these risk-reduction behaviors may well have helped reduce HIV infection in Sydney, where HIV testing rates are high and "a strong MSM community may reduce stigma and discrimination and foster a climate of open communication and responsibility."

"These conditions will certainly be different for many other groups of MSM, such as non-urban MSM, urban MSM of lower socio-economic status, and MSM outside of the Western world," he cautioned. Thus, "we need to be careful in generalizing the results" of the Australian study to HIV prevention programs elsewhere.

1/16/09

References

F Jin, J Crawford, P Garrett, and others. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS 23(2): 243-252. January 14, 2009. (Abstract).

SF Morin, SB Shade, WT Steward, and others (Healthy Living Project Team). A Behavioral Intervention Reduces HIV Transmission Risk by Promoting Sustained Serosorting Practices Among HIV-Infected Men Who Have Sex With Men. Journal of Acquired Immune Deficiency Syndromes 49(5): 544-551. December 2008. (Abstract).

F van Griensven. Non-condom use risk-reduction behaviours: can they help to contain the spread of HIV infection among men who have sex with men? AIDS 23(2): 253-255. January 14, 2009.

Related Posts Plugin for WordPress, Blogger...